Functional characterization of Arabidopsis thaliana transthyretin-like protein by Pessoa, João et al.
RESEARCH ARTICLE Open Access
Functional characterization of Arabidopsis thaliana
transthyretin-like protein
João Pessoa
1, Zsuzsa Sárkány
1, Frederico Ferreira-da-Silva
1, Sónia Martins
1, Maria R Almeida
1,2, Jianming Li
3,
Ana M Damas
1,2*
Abstract
Background: Arabidopsis thaliana transthyretin-like (TTL) protein is a potential substrate in the brassinosteroid
signalling cascade, having a role that moderates plant growth. Moreover, sequence homology revealed two
sequence domains similar to 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline (OHCU) decarboxylase (N-terminal
domain) and 5-hydroxyisourate (5-HIU) hydrolase (C-terminal domain). TTL is a member of the transthyretin-related
protein family (TRP), which comprises a number of proteins with sequence homology to transthyretin (TTR) and
the characteristic C-terminal sequence motif Tyr-Arg-Gly-Ser. TRPs are single domain proteins that form tetrameric
structures with 5-HIU hydrolase activity. Experimental evidence is fundamental for knowing if TTL is a tetrameric
protein, formed by the association of the 5-HIU hydrolase domains and, in this case, if the structural arrangement
allows for OHCU decarboxylase activity. This work reports about the biochemical and functional characterization of
TTL.
Results: The TTL gene was cloned and the protein expressed and purified for biochemical and functional
characterization. The results show that TTL is composed of four subunits, with a moderately elongated shape. We
also found evidence for 5-HIU hydrolase and OHCU decarboxylase activities in vitro, in the full-length protein.
Conclusions: The Arabidopsis thaliana transthyretin-like (TTL) protein is a tetrameric bifunctional enzyme, since it
has 5-HIU hydrolase and OHCU decarboxylase activities, which were simultaneously observed in vitro.
Background
The Arabidopsis thaliana transthyretin-like protein
(TTL) was first identified as a potential substrate of
Brassinosteroid-Insensitive 1 (BRI1), the principal brassi-
nosteroid (BR) receptor, playing a negative role in BR-
mediated plant growth [1].
Sequence analysis shows that TTL displays an N-
terminal domain corresponding to 2-oxo-4-hydroxy-4-
carboxy-5-ureidoimidazoline (OHCU) decarboxylase,
and a C-terminal domain that has approximately 42%
sequence identity with transthyretin (TTR), a vertebrate-
specific transport protein [1,2]. TTR is a plasma protein
which transports the thyroid hormones 3,5,3’,5’-tetra-
iodo-L-thyronin (T4) and 3,5,3-triiodo-L-thyronin (T3)
as well as retinol by association with the retinol-binding
protein [3]. TTRs are homotetrameric proteins, each
monomer containing two four-stranded b-sheets and
one short a-helix. They have a channel that runs
through the dimer-dimer interface, where two identical
thyroid hormone binding sites are located [4,5]. Proteins
with sequence homology to TTR and with the charac-
teristic C-terminal sequence motif Tyr-Arg-Gly-Ser,
which is absent in TTRs, are named transthyretin-
related proteins (TRPs) and are found in bacteria, fungi,
animals (both vertebrate and invertebrate) and plants
[2,6,7]. TRPs are thought to be TTR ancestors [2,7].
Three TTL splice variants were reported; two of them
are cytoplasmic (311- and 286-residues each) and the
other one is peroxisomal (324-residues) [8]. In all three
variants the N-terminal domain, OHCU decarboxylase,
is composed of 180 amino acids, whereas the C-terminal
domain varies in length, having 144, 131 and 106 amino
acids for the 324-, 311- and 286-residues isoforms,
respectively [2,8]. The 324-residues isoform contains a
type-2 peroxisomal targeting sequence (PTS-2), which is
deleted in the other two isoforms [2,8]. In most eukar-
yotes, 5-HIU hydrolases contain a PTS-2 and OHCU
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sequence (PTS-1), except in plants [9]. In A. thaliana
these two enzymes are fused into a single polypeptide
chain, containing a PTS-2 sequence, between the two
domains, in the 324-residues isoform.
In a previous study, the C-terminal domain of TTL
was expressed and studied separately. This single-
domain was named transthyretin-like protein (TLP) [2]
and is distinct from TTL, which contains both this C-
terminal domain, with 5-HIU hydrolase activity, and a
N-terminal domain, with OHCU decarboxylase activity,
fused into the same polypeptide chain [8]. TLP was
described as a tetramer [2]. The three-dimensional
structure of TRPs from Salmonella Dublin, Escherichia
coli, zebrafish and the homologous domain from Bacil-
lus subtilis were determined [10-13]. The overall struc-
tures of these TRPs and also the model predicted for
TLP [2] are very similar to those of TTRs, as expected
due to sequence homology, although functionally they
are different proteins. TRPs are hydrolases with a role
in uric acid degradation [7,14] and they do not bind
thyroid hormones [2,6]. TTL is the A. thaliana TRP
member, which contains an extra domain of 180
amino acids as compared to other TRPs. Until now,
only TRPs from Magnetospirillum magnetotacticum,
Bradyrhizobium japonicum,Bacillus subtilis and plant
species have been described as composed of two
sequence domains, one related to TTR and the other
with features common to OHCU decarboxylases
[2,7,9].
TTL was predicted by sequence homology as being a
bifunctional enzyme with 5-hydroxyisourate (5-HIU)
hydrolase and OHCU decarboxylase activities, catalysing
the two final steps in the uric acid degradation pathway
( F i g .1 )[ 8 ] .I nm o s to r g a n i s m s ,u r i ca c i d ,t h ee n dp r o -
duct of purine degradation, is catabolised to allantoin.
The process is initiated by uricase, which oxidizes uric
acid into 5-HIU; this intermediate compound is then
hydrolysed by 5-HIU hydrolase, leading to OHCU.
Finally, a third enzyme, OHCU decarboxylase, catalyses
the decarboxylation of OHCU producing (S)-allantoin
[9]. The spontaneous degradation of uric acid follows
the same pathway, resulting into 5-HIU and OHCU
intermediates, which can be further oxidized, producing
potentially harmful reactive species. However, many
organisms have an enzymatic pathway, possibly to con-
vert these intermediates more rapidly into allantoin, a
much less reactive species. The spontaneous pathway
produces racemic allantoin, whereas the enzymatic path-
way produces exclusively (S)-allantoin [9].
So far, two different functions have been assigned to
TTL: i) a signalling role to the cytoplasmic isoforms and
ii) an enzymatic role to the peroxisomal isoform. While
the signalling role has already been studied [1], it is not
known if the two enzymatic sequence domains that are
in this protein fused into a long polypeptide chain do
Figure 1 The uric acid degradation pathway.
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form. In this work we studied the 311-residue cytoplas-
mic isoform, referred as TTL throughout the manu-
script, to address the protein enzymatic role.
Results
TTL oligomerization state
Recombinant TTL was purified and used to investigate
the protein oligomerization state. We decided to use the
method developed by Siegel and Monty in 1966 [15],
because it allows calculation of the molecular mass of a
protein independently of its shape, using a combination
of the Stokes radius (a) derived from gel filtration chro-
matography and the sedimentation coefficient (S)
obtained from density gradient centrifugation. The gel
filtration chromatograms are presented in Fig. 2, show-
ing in Fig. 2A a major peak of oligomeric TTL and in
Fig. 2B superposed chromatograms of standard Stokes
radius markers. Using the equations described in Meth-
ods, section on “Determination of the protein oligomeric
state”, a and S were estimated to be 5.3 nm and 6.3 S,
respectively, and with these values the native molecular
mass for TTL was estimated to be 137.3 kDa. Since
each TTL subunit has 36.6 kDa, we concluded that TTL
is a tetramer, which is in agreement with the fact that
TTR, as well as A.thaliana TLP, also have a tetrameric
structure [2]. Moreover, the calculated frictional ratio,
1.5, is consistent with a moderately elongated non-glob-
ular protein [15].
Thyroxin (T4)-binding assays
Since TTR is a tetramer with two equivalent T4-binding
sites, we decided to study the binding of T4 to TTL,
using radiolabeled thyroxin and TTR as the sample con-
trol (Fig. 3). The TTR control has the typical behaviour
of a specific T4-binding protein, in which the increase of
cold T4 concentration causes the displacement of speci-
fically bound radiolabeled T4 *. On the contrary, T4
*-binding to TTL, besides being very low, was constant
at different T4 concentrations, showing a non-specific
binding. This is a very different behaviour as compared
to TTR, for which non-specific binding was only
detected at the highest T4 concentration. We concluded
that the binding of T4 to TTL is not significant and
clearly non-specific, since it is not altered in the pre-
sence of a competitor.
Sequence alignment of human TTR, TTL and TRPs
from Salmonella dublin, B. subtilis and mouse are pre-
sented in Fig. 4. As mentioned previously, only the C-
terminal domain of TTL has homology with TTR or
TRPs. Several amino acids were reported as important
for the binding of T4 to TTR, namely Lys15, Glu54,
Figure 2 Analytical gel filtration chromatograms for determination of TTL Stokes radius. (A) shows a chromatogram of recombinant TTL
(elution volume: 11.4 ml). In (B), two chromatograms of standard Stokes radius markers are superposed, where 1 refers to ferritin (Stokes radius:
6.1 nm; elution volume: 10.7 ml), 2 to aldolase (4.81 nm; 12.0 ml), 3 to albumin (3.55 nm; 12.4 ml), 4 to ovalbumin (3.05 nm; 13.3 ml) and 5 to
chymotrypsinogen A (2.09 nm; 15.3 ml).
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Page 3 of 10Thr106 and Thr119 [5]. Interestingly, they are not con-
served in TTL, being replaced by His196, Arg245,
His295 and Tyr308, respectively (Fig. 4), which are
amino acids conserved in TRPs, and were reported to
be important for 5-HIU hydrolase catalytic activity
[10,13,16]. According to our sequence alignment data
(Fig. 4) and the three-dimensional structure of several
TTR and TRP proteins [5,10-13], these substitutions will
probably have two main effects: i) create a narrower
region at the inner part of the binding site due to the
replacement of Thr for Tyr, which has a larger side
chain and ii) alter the surface topography and introduce
charge differences at the entrance of the channel, due to
substitutions Lys-His, Glu-Arg and Thr-His. These
modifications will probably exclude the binding of T4 to
TRPs and TTL.
TTL enzymatic activities
Since TRPs are functionally associated to 5-HIU hydro-
lases, we decided to study the predicted 5-HIU hydro-
lase and OHCU decarboxylase activities for TTL in
vitro. The experiments were started by testing how TTL
would affect the activity of uricase over uric acid by
monitoring the differences in absorbance at 292 nm in
the absence or presence of TTL (Fig. 5). Although uri-
case alone was able to decompose uric acid, its activity
was significantly accelerated in the presence of TTL. By
contrast, TTR did not influence this reaction. This result
is consistent with the predicted 5-HIU hydrolase and
OHCU decarboxylase activities. The rapid consumption
of 5-HIU and OHCU should favour an equilibrium shift
in the reaction catalysed by uricase.
5-HIU hydrolase activity was demonstrated in vitro for
single-domain TRPs present in S. dublin, B. subtilis and
mouse [10,14,16]. The authors reported that uric acid
w a sc o n v e r t e di n t o5 - H I Ub yu r i c a s ea n db o t ht h ef o r -
mation and subsequent degradation of this compound
was monitored at 312 nm, since OHCU does not absorb
at this wavelength [17]. In our assay conditions, within
60 seconds incubation of uric acid with the Candida sp.
uricase, the production of 5-HIU reached the maximum
level (Fig. 6). At this point, TTL was added to the reac-
tion solution resulting in a rapid decrease in absorbance
at 312 nm (Fig. 6). As expected, addition of TTR, which
was used as the negative control, failed to accelerate 5-
HIU degradation. This result shows that TTL is an
enzyme that facilitates the hydrolysis of 5-HIU and also
indicates that most probably four protein C-terminal
domains associate forming a tetrameric structure, since
the 5-HIU hydrolase catalytic site are located at the
dimer-dimer interface in all structurally and functionally
characterised TRP members [10,13].
Although the crystal structure of the N-terminal
OHCU domain of TTL from A. thaliana, which con-
tains conserved residues critical for the OHCU decar-
boxylase activity, was recently reported [18], its
predicted enzyme activity was not experimentally
demonstrated. In fact, it was only observed in vitro in
Figure 3 T4-binding assay. The percentage of binding of radioactive T4 * was gradually reduced by increasing the concentration of T4 in the
TTR solution, but not in TTL. Each curve is representative of two independent measurements and standard deviations are indicated by error bars.
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subtilis and also in zebrafish OHCU decarboxylase
[18,19]. Monitoring the decarboxylase activity of TTL by
spectrophotometry is not straightforward since OHCU
absorbs below 300 nm and its absorption spectrum
overlaps with that of 5-HIU [17]. Therefore, measure-
ments at 257 nm are likely to be a sum of contributions
by 5-HIU and OHCU. However, the spontaneous degra-
dation observed at this wavelength is clearly distinct
from what is observed at 312 nm (Fig. 7). The sponta-
neous degradation followed at 312 nm shows that 5-
HIU is completely degraded in 2640 seconds (from 60 s
to 2700 s Fig. 7), thus the spontaneous absorbance
decay measured after this point at 257 nm (marked with
dash line in Fig. 7) is exclusively due to the spontaneous
degradation of OHCU. Therefore this degradation was
used as control in the experiments testing the effect of
TTL on degradation of OHCU.
Figure 4 Sequence alignment of human TTR, TTL and TRPs from mouse (mTRP), S. dublin (SdTRP) and B. subtilis (BsTRP).A m i n oa c i d s
involved in the binding of T4 to TTR and their substitutes in TTL and TRPs are presented in black. Sequence alignment was obtained using
ClustalW [24].
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Page 5 of 10Figure 5 Uricase activity is accelerated by TTL. The enzymatic oxidation of uric acid was monitored by decrease in absorbance at 292 nm.
Uricase was pre-incubated with TTL or TTR for 5 minutes at 22°C and then uric acid was added to start the reaction. TTR was used as negative
control.
Figure 6 5-HIU hydrolase activity of TTL. Uricase was pre-incubated with uric acid to produce 5-HIU. When the absorbance measured at 312
nm reached its maximum (in approximately 60 seconds), TTL or TTR were added. The observed absorbance decrease was monitored for the
degradation of 5-HIU, which was complete in 100 seconds (from 60 to 160 seconds).
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at 312 nm was completed in 100 seconds (from 60 s to
160 s in Fig. 6) therefore after this point the absorbance
decay measured at 257 nm (marked with a dash line in
Fig. 8) corresponds to the degradation of OHCU
affected by TTL. The rate of this degradation is exces-
sively high as compared to the control spontaneous
degradation of OHCU (Fig. 8). Addition of TTL acceler-
ated significantly the degradation of OHCU, supporting
the decarboxylase activity of the protein.
Taken together, our results demonstrated that TTL
has 5-HIU hydrolase and OHCU decarboxylase activities
in vitro, and they are both performed at the same time.
Discussion
I ts e e m st h a tt h eT T Rd o m a i ne v o l v e df r o ma ne n z y m e
present in bacteria, fungi, plants and animals to a hor-
mone transporter present in vertebrates [2,7,12]. Its
function changed completely, although there are only
minor differences in sequence. In the present study, we
showed that TTL from A. thaliana is a tetramer with a
moderately elongated shape. The tetrameric structure is
in agreement with the observation that the protein has
5-HIU hydrolase activity. We expect that four C-term-
inal domains associate in a tetramer forming two active
sites, as reported for TRPs, which contain only one
domain. Moreover, the elongated shape is possibly due
to the N-terminal OHCU decarboxylase domain asso-
ciated to each of the four C-terminal sequences forming
the tetramer. The molecular model of this domain was
determined in the presence of allantoin [18]; it is an
alpha-domain that associates as dimers in its crystal
form. However, a careful inspection of the available
molecular models for TRPs and OHCU decarboxylase
domain indicates that allantoin binding site is not in the
region of the interaction between the two subunits that
form the dimer [18] and this kind of association most
probably will not be present in TTL, since the TTL tet-
ramer will be formed through contacts among the C-
terminal domains.
We also demonstrated that TTL does not bind T4 in
vitro, corroborating the observation that the ligand-
binding site has characteristics which are different from
those present in TTR. These results are in agreement
with previous observations, since the functionally char-
acterized TRPs do not bind thyroid hormones [2,6] and
are 5-HIU hydrolases with active sites located in the
regions corresponding to the T4-binding sites in TTR
[7,10,12,13]. The OHCU decarboxylase activity was
also detected in the full-length TTL, indicating that the
Figure 7 Spontaneous degradation of 5-HIU and OHCU. Uricase was pre-incubated with uric acid during 60 seconds to produce 5-HIU (data
not shown) and degradation was followed at 312 nm. The degradation of both 5-HIU and OHCU was followed at 257 nm. Since spontaneous
degradation of 5-HIU is complete in 2640 seconds (from 60 to 2700 seconds), as verified at 312 nm, after this point (marked with dash line),
absorbance curve at 257 nm is exclusively due to the spontaneous degradation of OHCU. (X axis starts at 60 s).
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formed by the C-terminal regions; the reverse is also
valid, thus supporting the idea of a bifunctional enzyme.
TTL was initially characterized as a specific BRI1-inter-
actor that regulates BR-mediated plant growth [1]. Here
we show that the same protein is also enzymatically
active. Several proteins with at least two totally different
functions have been reported and named moonlighting
proteins; the switch between functions is due to changes
in cellular localization, cell type, oligomeric state or cellu-
lar concentration of a ligand [20,21]. We think that TTL
is a moonlighting protein that switches its function
according to its subcellular location. In eukaryotes, per-
oxisomes are the major organelles where oxidative reac-
tions with molecular oxygen consumption are carried
out. In these organisms, uricase is located in peroxi-
somes, oxidizing uric acid to 5-HIU [9]. As a conse-
quence, 5-HIU accumulates in peroxisomes, providing
the initial TTL substrate. Therefore, in peroxisomes,
where uric acid degradation occurs, TTL, through its
324-residues isoform, functions as a bifunctional enzyme
with 5-HIU hydrolase and OHCU decarboxylase activ-
ities. In the cytoplasm, 5-HIU and OHCU are absent,
since they are produced in peroxisomes. Consequently,
the TTL 311-residues isoform most probably will not
have these enzymatic functions. Moreover, it was shown
to interact with BRI1, mediating BR-regulated plant
growth. BRI1 is an intrinsic membrane protein, located
in the plasma membrane and containing a cytoplasmic
kinase domain that interacts with TTL [1]. The main dif-
ference between the 324- and 311-residues isoforms is
the presence or absence of PTS-2. The subcellular loca-
tion of three TTL isoforms is probably fundamental to
define their role in vivo. TTL 324-residues isoform loca-
tion into peroxisomes was already shown by fluorescence
microscopy, and provided conclusive results regarding its
import [8]. It was also observed that its import efficiency
was low and it was hypothesized that could result from a
low accessibility of the internal targeting signal to the
peroxisomal import machinery. Internal PTS-2 signal
sequences are thought to be rare in nature and to occur
preferentially in bifuctional enzymes resulting from gene
Figure 8 OHCU decarboxylase activity of TTL. Uricase was pre-incubated with uric acid to produce 5-HIU. When the absorbance measured at
257 nm reached its maximum (in approximately 60 seconds), TTL was added. Since in presence of TTL, 5-HIU is completely degraded in 100
seconds (from 60 to 160 seconds; see Fig. 6), the absorbance decay after this point (marked with a dash line) measured at 257 nm is only due
to OHCU degradation. The equivalent control for the spontaneous degradation of OHCU was built from Fig. 7 (in this case the time was marked
in the upper X axis). Starting from the dashed line, both X axes show the same time period of 390 seconds (160 to 550 seconds and 2700 to
3090 seconds).
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in the cytoplasm in vivo, since it does not contain the
PTS-2 sequence [1,8]. Therefore in the absence of uric
acid degradation intermediates, it interacts with the
plasma membrane-located BRI1, mediating BR-regulated
plant growth [1].
Attempts for the three-dimensional structure determi-
nation of TTL are in progress and should represent a
fundamental step in order to clarify TTL function,
namely its signalling role in BR-mediated responses.
Conclusions
The aminoacid sequence of TTL from A. thaliana
r e v e a l st w od o m a i n ss i m i l a rt o5 - H I Uh y d r o l a s ea n d
OHCU decarboxylase. As a consequence, TTL was pre-
dicted to be a bifunctional enzyme. Here we reported
the first experimental data showing that in fact the pro-
tein has both enzymatic activities in vitro. Moreover, we
confirmed that TTL is in fact a bifunctional enzyme, by
showing that it performs both activities simultaneously.
Methods
Cloning, expression and purification of A. thaliana TTL
TTL ORF was amplified by PCR and cloned into pET-
28a(+) (Novagen). Recombinant TTL was overexpressed
in E. coli BL21 (DE3) codon plus and purified as follows:
cells were grown in LB at 37°C to OD600 =0 . 8a n d
expression induced with 1 mM IPTG for 18 hours at
20°C. Cells were harvested (10500 g, 20 minutes),
ressuspended in 140 mM NaCl, 2.7 mM KCl, 1.0 mM
KH2PO4,5 0μg/ml lysozyme, 1 mM phenylmethylsulfo-
nyl fluoride (PMSF), 1 μg/ml DNase I, 100 μMM g C l 2,
10 mM Na2HPO4, pH 7.4 and lysed by sonication.
Lysates were centrifuged (27200 g, 20 minutes), super-
natants filtered and loaded onto a 5 ml HisTrap HP col-
umn (GE Healthcare) previously equilibrated with buffer
A (20 mM imidazole, 500 mM NaCl, 20 mM NaH2PO4/
Na2HPO4, pH 7.4). After a washing step with 20% buffer
B (500 mM imidazole, 500 mM NaCl, 20 mM
NaH2PO4/Na2HPO4, pH 7.4), TTL was eluted with 50%
buffer B. Fractions containing His-tagged TTL were dia-
lyzed against buffer A followed by buffer C (150 mM
NaCl, 1 M EDTA, 20 mM Tris-HCl, pH 8.0), concen-
trated and loaded onto a HiPreP 26/60 Sephacryl S-300
HR column (GE Healthcare). After an isocratic elution
in buffer C, TTL containing fractions were pooled and
concentrated to 7 mg/ml. Protein concentration was
determined by absorption at 280 nm using a theoretical
49430 M
-1cm
-1 molar extinction coefficient [22].
Determination of the protein oligomeric state
For analytical size-exclusion chromatography a Superose
12 10/300 column (GE Healthcare) was equilibrated
with buffer C at 0.5 ml/min and calibrated with protein
standards of known Stokes radius. The Stokes radius
(a) for the experimental data was calculated using:
(-logKav)
1/2 =f ( a). For isokinetic rate zonal ultracentrifu-
gation, two continuous gradients of 5 to 20% sucrose
(Merck) were prepared in buffer C, calibrated with stan-
dard proteins of known sedimentation coefficient and
ran for 25 hours and 15 minutes at 260800 g in a Beck-
man SW41 Ti rotor. TTL native molecular mass (M)
and frictional ratio (f/f0) were calculated according to
Siegel and Monty [15], using the following equations:
M
Ns
v
 v M N



6
1
34 13 0



a
ff
a
/
(( )/( ) /
where M represents the molecular mass, a the Stokes
radius, s the sedimentation coefficient, v the partial spe-
cific volume, f/f0 the frictional ratio, h the viscosity of
the medium, r the density of the medium and N Avoga-
dro’s constant. Partial specific volume for TTL was cal-
culated from the amino acid sequence of the protein
using the program SEDNTERP v1.08 http://www.jphilo.
mailway.com/default.htm.
Thyroxin-binding assays
The assays were performed as previously described [23],
using 100 nM TTR or TTL, 5-10 × 10
4 counts per min-
ute (cpm) radiolabeled thyroxin,
125I-T4 (T4 *) (Perkin
Elmer) and different cold T4(Sigma) concentrations.
Counts were measured in a Wallac 1470 wizard™ auto-
matic gamma counter.
Enzyme assays
The enzymatic assays were based on previously
described procedures for enzymes with sequence simi-
larity to the TTL hydrolase domain [10,14]. Briefly,
500 μl assay mixtures contained 0.05 units/ml uricase
from Candida sp. (Sigma) in 50 mM potassium phos-
phate buffer pH 7.8. When 50 μM uric acid (Sigma)
were added, 5-HIU and OHCU were generated in situ
and their degradation was followed at 312 nm and 257
nm, in the presence and absence of 0.003 μM TTL or
TTR. TTL effect on uricase activity was monitored at
292 nm in the same conditions. Triplicate measure-
ments were done aerobically at 22°C.
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